BRD7 Antikörper (C-Term)
(1 reference)Kurzübersicht für BRD7 Antikörper (C-Term) (ABIN2780896)
Target
Alle BRD7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Sequenz
- KELAQQVTPG DIVSTYGVRK AMGISIPSPV MENNFVDLTE DTEEPKKTDV
-
Homologie
- Dog: 86%, Guinea Pig: 93%, Horse: 79%, Human: 100%, Rabbit: 79%, Rat: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against BRD7. It was validated on Western Blot using a cell lysate as a positive control.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the C terminal region of human BRD7
-
-
anti-Bromodomain Containing 7 (BRD7) (Internal Region) antibody
BRD7 Reaktivität: Human, Maus, Ratte WB, IHC, IF, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 1-95) antibodyBRD7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 601-651) antibodyBRD7 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 387-418) antibodyBRD7 Reaktivität: Maus WB Wirt: Kaninchen Polyclonal RB43270 unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 514-567) antibodyBRD7 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 77-106), (N-Term) antibodyBRD7 Reaktivität: Maus WB Wirt: Kaninchen Polyclonal RB32783 unconjugated
anti-Bromodomain Containing 7 (BRD7) (AA 1-651) antibodyBRD7 Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Bromodomain Containing 7 (BRD7) (C-Term) antibodyBRD7 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 651 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells." in: Respiratory physiology & neurobiology, Vol. 140, Issue 1, pp. 89-97, (2004) (PubMed).
-
: "Yersinia YopJ inhibits pro-inflammatory molecule expression in human bronchial epithelial cells." in: Respiratory physiology & neurobiology, Vol. 140, Issue 1, pp. 89-97, (2004) (PubMed).
-
- BRD7 (Bromodomain Containing 7 (BRD7))
-
Andere Bezeichnung
- BRD7
-
Hintergrund
-
BRD7 is an activator of the Wnt signaling pathway in a DVL1-dependent manner by negatively regulating the GSK3B phosphotransferase activity. It induces dephosphorylation of GSK3B at 'Tyr-216'.
Alias Symbols: BP75, CELTIX1, NAG4
Protein Interaction Partner: UBC, Dvl1, HIST2H3C, BRD2, NEFL, BARD1, LRIF1, HAP1, TFAP4, TRIM24, SUMO2, SMARCE1, SMARCD1, SMARCC2, Bcl7b, CHD7, ARID2, RBFOX2, BCL7C, SMARCC1, SMARCA4, PCBD1, POU2F1, MYC, BRCA1, BHLHE40, HIST2H4A, HIST2H3A, BTBD2, RIF1, HNRNPUL1, HIST1H2AL, AGR2, PSMD
Protein Size: 651 -
Molekulargewicht
- 74 kDa
-
Gen-ID
- 29117
-
NCBI Accession
- NM_013263, NP_037395
-
UniProt
- Q9NPI1
Target
-
